In a patient with chronic inflammatory demyelinating polyneuropathy and a history of gastro‑oesophageal reflux disease, hypertension, and obstructive sleep apnoea, would a hyperfunctional (exaggerated) adductor reflex be expected?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

No, a hyperfunctional adductor reflex would NOT be expected in CIDP

Chronic inflammatory demyelinating polyneuropathy (CIDP) characteristically causes reduced or absent deep tendon reflexes, not hyperreflexia. A hyperfunctional (exaggerated) adductor reflex would be inconsistent with the typical presentation of CIDP and should prompt consideration of alternative or concurrent diagnoses.

Why CIDP Does Not Cause Hyperreflexia

CIDP is an autoimmune demyelinating neuropathy affecting peripheral nerves, characterized by:

  • Progressive proximal and distal weakness affecting upper and lower extremities
  • Sensory loss (variable)
  • Depressed or absent muscle stretch reflexes 1, 2, 3, 4

The pathophysiology involves demyelination of peripheral nerves, which disrupts the reflex arc at the peripheral level. This results in hyporeflexia or areflexia, not hyperreflexia 1, 2.

Clinical Implications

If you observe a hyperfunctional adductor reflex in a patient with suspected CIDP, consider:

  1. Upper motor neuron pathology - Hyperreflexia indicates central nervous system involvement (spinal cord or brain), not peripheral neuropathy
  2. Misdiagnosis - The patient may not have CIDP but rather a central demyelinating condition or other CNS disorder
  3. Concurrent pathology - Two separate neurological processes may coexist

Regarding the Comorbidities

The patient's background conditions (GORD, HTN, OSA) are not relevant to reflex examination findings in CIDP:

  • GORD - No neurological impact on reflexes
  • Hypertension - Does not cause hyperreflexia unless complicated by stroke or hypertensive encephalopathy
  • OSA - May be associated with CIDP as a comorbidity 5 but does not alter reflex patterns

Diagnostic Approach

When evaluating reflexes in suspected CIDP:

  • Expected finding: Reduced or absent ankle reflexes, often progressing to involve other reflexes 6, 2
  • Red flag: Hyperreflexia, upgoing plantar responses, or spasticity suggest CNS involvement
  • Action if hyperreflexia present: Obtain spinal cord imaging (MRI) to exclude myelopathy, consider alternative diagnoses including combined central and peripheral nervous system disorders

The presence of hyperreflexia fundamentally contradicts the peripheral nerve pathology that defines CIDP 1, 2, 3.

Related Questions

In a patient with chronic inflammatory demyelinating polyneuropathy (CIDP) who speaks normally in conversation but develops a severely strangulated voice with absent airflow and phonation on sustained phonation attempts that end in coughing, what is the likely cause and is this a functional (psychogenic) voice disorder?
In a 22-year-old man with subacute ascending progressive motor‑sensory demyelinating polyneuropathy, severe neutropenia, mild thrombocytopenia, anemia, and hepatosplenomegaly, what is the most likely diagnosis and what immediate diagnostic and therapeutic steps should be taken?
In a patient with well‑controlled diabetes and hypertension who presents with burning pain, numbness, paresthesias, gait instability, and autonomic dysfunction while taking amiodarone, is his neuropathy more likely due to amiodarone‑induced neurotoxicity rather than chronic inflammatory demyelinating polyneuropathy (CIDP)?
What is the recommended diagnostic workup and initial treatment for a suspected inflammatory demyelinating polyneuropathy such as chronic inflammatory demyelinating polyneuropathy?
In a patient with distal burning pain, numbness, paresthesias, gait instability, spasticity, a positive Babinski sign, and bowel/bladder dysfunction, could chronic inflammatory demyelinating polyneuropathy (CIDP) be the primary diagnosis, or should it be considered only as a possible coexisting peripheral neuropathy?
In an adult with an acute respiratory infection (e.g., viral bronchitis or COVID‑19) who develops concurrent joint pain, how should the joint pain be evaluated and managed?
What is the appropriate diagnostic workup and management for a proximal tibial lytic lesion with cortical destruction and extraosseous extension suggestive of an aggressive bone tumor?
How should a continuous intravenous furosemide infusion be administered?
How should COPD with eosinophilia (blood eosinophil count ≥300 cells/µL) be managed?
What is the recommended management of emphysematous pyelonephritis?
What is the appropriate dosing and administration protocol for a continuous intravenous furosemide infusion in a 66‑kg patient with an intracranial mass?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.